Analysis of multiple compound-protein interactions reveals novel bioactive molecules
about
Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive reviewBenchmark of four popular virtual screening programs: construction of the active/decoy dataset remains a major determinant of measured performancePrediction of chemical-protein interactions network with weighted network-based inference methodA systematic prediction of multiple drug-target interactions from chemical, genomic, and pharmacological dataLigand-target prediction by structural network biology using nAnnoLyzeA Multilayer Network Approach for Guiding Drug Repositioning in Neglected DiseasesDrugE-Rank: improving drug-target interaction prediction of new candidate drugs or targets by ensemble learning to rankStructural bioinformatics of the interactome.Drug-target interaction prediction by integrating chemical, genomic, functional and pharmacological data.Scalable prediction of compound-protein interactions using minwise hashingImproving compound-protein interaction prediction by building up highly credible negative samples.The chemical interactome space between the human host and the genetically defined gut metabotypes.Predicting drug-target interactions using restricted Boltzmann machines.Development of conformation independent computational models for the early recognition of breast cancer resistance protein substrates.Quantitative Structure-activity Relationship (QSAR) Models for Docking Score Correction.Similarity-based machine learning methods for predicting drug-target interactions: a brief review.On protocols and measures for the validation of supervised methods for the inference of biological networksComputational methods for analysis and inference of kinase/inhibitor relationships.Constructing a Foundational Platform Driven by Japan's K Supercomputer for Next-Generation Drug Design.Using quantitative systems pharmacology for novel drug discovery.Network-based Approaches in Pharmacology.Active learning for computational chemogenomics.CompoundProtein Interaction Prediction Within Chemogenomics: Theoretical Concepts, Practical Usage, and Future Directions.Benchmarking a Wide Range of Chemical Descriptors for Drug-Target Interaction Prediction Using a Chemogenomic Approach.Physicochemical characteristics of structurally determined metabolite-protein and drug-protein binding events with respect to binding specificity.Best of both worlds: on the complementarity of ligand-based and structure-based virtual screeningGlobal optimization-based inference of chemogenomic features from drug-target interactions.Identification of chemogenomic features from drug-target interaction networks using interpretable classifiers.Flaws in evaluation schemes for pair-input computational predictions.SimBoost: a read-across approach for predicting drug-target binding affinities using gradient boosting machines.Predicting drug targets based on protein domains.Novel inhibitor candidates of TRPV2 prevent damage of dystrophic myocytes and ameliorate against dilated cardiomyopathy in a hamster model.Polypharmacology modelling using proteochemometrics (PCM): recent methodological developments, applications to target families, and future prospectsMapping the 3D structures of small molecule binding sites.
P2860
Q27008867-96E2AE47-6F22-48DD-A0C3-28F5218935F1Q27902269-DFF6F7F0-6826-4215-BD19-3DCC06622AABQ28481329-FCD784E1-C9C5-4B48-8C66-B60A17538CFBQ28484011-B2AA9379-7847-47BA-80D1-2D78380FF636Q28545126-5A79D1BE-840B-4848-9908-7D38F54D2C15Q28552140-70181EAE-CA06-4590-B004-5894F8A6735BQ28830286-021DCE57-CB21-460B-96AE-D7841EA87A04Q30363264-A675EB80-4592-4F28-A904-2E9F2B9852F8Q30705795-5B0C525D-3073-4C94-A7F1-68D5EA851280Q35101862-BFAA7D07-2EB1-4C2E-81AC-68AD4AE0FA19Q36614015-294709A0-1BF9-4DA8-BF43-4159E4B86B66Q36702250-1D6A5970-61A7-481A-AC46-F7583F7DD51BQ36960730-660B4D02-1145-46C7-BBCD-B39B7B5F81C2Q37105057-E18C6E06-207F-4CDA-A561-B4464DDE3D58Q37631873-05DB201B-A7CD-4D27-BC1D-568EEF1BDAA3Q38128158-07484CB2-B781-4561-A893-4951AB3E2742Q38172136-ACDD1B2A-4974-4CCF-BCAC-0DC50E7D6EE1Q38234965-E2C7C372-96EE-48DF-8C0B-402824608F72Q38393768-679F3FA2-A46F-4600-BF14-58A07FD698FAQ38578286-7345E447-9FCB-4156-B653-8260034EBCBAQ38686574-B975A978-B1DA-47CE-BB5A-8802B5FC7262Q38750215-6A42208E-17DF-4EF9-A2B0-7291F5562078Q38915500-BB764185-7B8C-4E89-8EF1-313A9F860ADFQ38916721-C5E202FE-C34A-4644-88E7-0156AAB1FDF4Q40460290-8EBCA3BE-ADA8-4F84-B00F-A985428A3694Q41093798-A2B031D9-2612-4ED0-BE49-4309E71E5E12Q41145083-94190269-6E44-476C-8F18-505A3A4094B2Q41816148-A25656F6-3D5F-4E3D-8E19-9C836282B350Q42431205-12EB3D44-2250-48EA-9582-D2D40678BAC8Q43118032-C25AAFE8-8031-4090-961F-28D23B76029DQ51406184-7B7A6449-E5B5-4A2C-AFEE-3571DD908E97Q51730320-4DFE0087-6298-4D6C-908C-3D712F4FD9C2Q54152494-1AF11C3A-49BD-40E6-A087-121FC1E1D928Q54572862-AE383E72-FBBA-4A05-97FF-48A5DCC693E0
P2860
Analysis of multiple compound-protein interactions reveals novel bioactive molecules
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Analysis of multiple compound-protein interactions reveals novel bioactive molecules
@ast
Analysis of multiple compound-protein interactions reveals novel bioactive molecules
@en
Analysis of multiple compound-protein interactions reveals novel bioactive molecules
@nl
type
label
Analysis of multiple compound-protein interactions reveals novel bioactive molecules
@ast
Analysis of multiple compound-protein interactions reveals novel bioactive molecules
@en
Analysis of multiple compound-protein interactions reveals novel bioactive molecules
@nl
prefLabel
Analysis of multiple compound-protein interactions reveals novel bioactive molecules
@ast
Analysis of multiple compound-protein interactions reveals novel bioactive molecules
@en
Analysis of multiple compound-protein interactions reveals novel bioactive molecules
@nl
P2093
P2860
P356
P1476
Analysis of multiple compound-protein interactions reveals novel bioactive molecules
@en
P2093
Gozoh Tsujimoto
Hiroaki Yabuuchi
Hiromu Takematsu
Satoshi Niijima
Takafumi Hara
Takatsugu Hirokawa
Teppei Ogawa
Tomomi Ida
Yasushi Okuno
Yohsuke Minowa
P2860
P356
10.1038/MSB.2011.5
P577
2011-03-01T00:00:00Z